Longitudinal analysis of the Non-Motor Symptoms Scale in Parkinson's Disease (NMSS): An exploratory network analysis approach.
Parkinson's disease
depression
dysautonomia
network analysis
non-motor symptoms
scales
symptom assessment
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
17
06
2022
accepted:
17
01
2023
entrez:
3
3
2023
pubmed:
4
3
2023
medline:
4
3
2023
Statut:
epublish
Résumé
Parkinson's disease (PD) is a multisystem neurodegenerative disorder characterized by motor and non-motor symptoms. In particular, non-motor symptoms have become increasingly relevant to disease progression. This study aimed to reveal which non-motor symptoms have the highest impact on the complex interacting system of various non-motor symptoms and to determine the progression of these interactions over time. We performed exploratory network analyses of 499 patients with PD from the Cohort of Patients with Parkinson's Disease in Spain study, who had Non-Motor Symptoms Scale in Parkinson's Disease ratings obtained at baseline and a 2-year follow-up. Patients were aged between 30 and 75 years and had no dementia. The strength centrality measures were determined using the extended Bayesian information criterion and the least absolute shrinkage and selection operator. A network comparison test was conducted for the longitudinal analyses. Our study revealed that the depressive symptoms Our results suggest that anhedonia and feeling sad are influential non-motor symptoms in the network and, thus, are promising targets for interventions as they are closely linked to other non-motor symptoms.
Identifiants
pubmed: 36864919
doi: 10.3389/fneur.2023.972210
pmc: PMC9971229
doi:
Types de publication
Journal Article
Langues
eng
Pagination
972210Informations de copyright
Copyright © 2023 Heimrich, Schönenberg, Mühlhammer, Mendorf, Santos-García and Prell.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Health Psychol Behav Med. 2018 Sep 25;6(1):301-328
pubmed: 34040834
Psychol Methods. 2021 Nov 29;:
pubmed: 34843277
Psychol Methods. 2018 Dec;23(4):617-634
pubmed: 29595293
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
Parkinsons Dis. 2011;2011:143547
pubmed: 21687804
Neurology. 2009 Nov 10;73(19):1584-91
pubmed: 19901251
J Pers Med. 2021 Jun 30;11(7):
pubmed: 34209166
Parkinsonism Relat Disord. 2002 Jan;8(3):193-7
pubmed: 12039431
Mov Disord. 2007 Oct 15;22(13):1901-11
pubmed: 17674410
Mov Disord. 2009 Aug 15;24(11):1641-9
pubmed: 19514014
Mov Disord. 2021 Dec;36(12):2888-2900
pubmed: 34494685
Am J Med. 1997 Nov;103(5):339-47
pubmed: 9375700
Psychol Methods. 2022 Apr 11;:
pubmed: 35404628
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
BMC Neurol. 2016 Feb 25;16:26
pubmed: 26911448
J Neurol Sci. 2020 Nov 15;418:117109
pubmed: 32927370
Mov Disord. 2002 May;17(3):445-54
pubmed: 12112190
Int Rev Neurobiol. 2017;132:33-54
pubmed: 28554413
Qual Life Res. 1995 Aug;4(4):293-307
pubmed: 7550178
J Neurol Sci. 2020 May 15;412:116641
pubmed: 32151836
Biostatistics. 2008 Jul;9(3):432-41
pubmed: 18079126
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110289
pubmed: 33631251
J Neurol Sci. 2021 Oct 15;429:117615
pubmed: 34492572
Behav Res Methods. 2018 Feb;50(1):195-212
pubmed: 28342071
Acta Neurol Scand. 2021 Jan;143(1):3-12
pubmed: 32813911
BMC Psychiatry. 2012 Oct 30;12:181
pubmed: 23110575
J Geriatr Psychiatry Neurol. 2021 Jan;34(1):60-65
pubmed: 32027207
Mov Disord. 2011 Feb 15;26(3):399-406
pubmed: 21264941
N Engl J Med. 1999 Oct 28;341(18):1329-35
pubmed: 10536124
J Clin Epidemiol. 1998 Nov;51(11):945-52
pubmed: 9817111
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Clin Geriatr Med. 2020 Feb;36(1):93-104
pubmed: 31733705
Lancet Neurol. 2018 Jun;17(6):559-568
pubmed: 29699914
Brain. 2005 Jun;128(Pt 6):1314-22
pubmed: 15716302
Lancet Neurol. 2006 Mar;5(3):235-45
pubmed: 16488379
Parkinsons Dis. 2021 Feb 8;2021:6621991
pubmed: 33628415